NCT00001255View on ClinicalTrials.gov

Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study

CompletedOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

September 30, 1990

Study Completion Date

July 31, 2002

Conditions

Severe Combined Immunodeficiency

Interventions

DRUG

ADA PBSC

DRUG

ADA Umbilical Cord Blood Cells

DRUG

Transduced Lymphocytes

Trial Locations (1)

20892

National Human Genome Research Institute (NHGRI), Bethesda

All Listed Sponsors

lead

National Human Genome Research Institute (NHGRI)

NIH